(Credit: Unsplash)This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Victoria Masterson. Senior Writer… Read More

Relapsed or Refractory Diffuse Large B-cell Lymphoma MarketDiffuse large B-cell lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma. It is the most common type of non-Hodgkin lymp… Read More

The advent of cell therapies, particularly those harnessing advanced cell engineering techniques initially developed for cancer treatment, offers a new frontier in the management, and potent… Read More

Switzerland-based, life science startup Limula raises €6.2 million in oversubscribed seed funding to take their solution for automating cell therapy manufacturing to the next stage of d… Read More

People with lymphoma may receive chemotherapy alone or a combination of chemotherapy and nonchemotherapy treatments, Dr. Ansell says. Nonchemotherapy options include immunotherapy, chimeric… Read More

Gritstone bio (GRTS) has unveiled promising preliminary data from its GRANITE personalized cancer vaccine program during its First Quarter 2024 Earnings Call. The clinical updates showed a… Read More

What matters in cancer |  View this email in your browser Thursday 9 May 2024… Read More

The Breakthrough Prize Ceremony, also known as “the Oscars of Science,” is an award show unlike any other. Founded and funded by Silicon Valley titan Yuri Milner and his ar… Read More

In the realm of oncology, the advent of cancer immunotherapy has brought a paradigm shift in treatment approaches. Harnessing the body’s immune system to combat cancer, immunotherapies… Read More

In the realm of medical research, the boundaries between diseases often blur as scientists uncover unexpected connections and novel treatment approaches. A promising alliance emerges in the… Read More

What matters in cancer |  View this email in your browser Thursday 28 March 2024… Read More

Cancer, a formidable adversary of human health, continues to challenge medical science and society at large. Its multifaceted nature demands a comprehensive understanding, innovative treatme… Read More

Welcome to CanWinn Foundation, your trusted partner in Top orthopedic disease treatment in Gurgaon. In a world where mobility and comfort are paramount, ensuring the health and functionality… Read More

The FDA’s latest guidance outlines crucial considerations for developing Chimeric Antigen Receptor (CAR) T cell products. Focused on safety, manufacturing, and clinical stud… Read More

[Research Report] The antibody discovery market size is projected to surge from US$ 2.94 billion in 2022 to US$ 4.92 billion by 2030; the market is estimated to grow at a CAGR of 6.7% d… Read More

Immune cell engineering is an emerging field that holds promise for developing next-generation cell therapies. By reprogramming a patient’s own immune cells, researchers are working to… Read More

Introduction to Cancer Cancer, a pervasive health challenge, is characterized by uncontrolled cell growth and poses significant physical, emotional, and socioeconomic burdens globally. Despi… Read More

The monoclonal antibody therapeutics market involves the production of monoclonal antibodies that help detect or combat diseases like cancer, cardiovascular diseases, and autoimmune disorder… Read More

Medical innovation refers to the development and introduction of new or improved medical technologies, treatments, drugs, devices, procedures, or healthcare delivery methods that lead to ad… Read More

The share price of the pharma stock rose by 1% to its intraday high of ₹827.10 per share from its previous close of ₹818.50 on Thursday after the company invested 2 million US do… Read More

CASGEVY approval CASGEVY is a groundbreaking gene therapy, owned by CRISPR AG (CRSP) and Vertex (VRTX) specifically designed for the treatment of sickle cell disease (SCD) in individuals… Read More

Allogeneic T Cell Therapies Market Outlook: The global allogeneic T cell therapies market size is anticipated to grow at a CAGR of 9.75% during the forecast period of 2024-2032, driven by th… Read More

Includes clinical-stage autologous BCMA/CD19 CAR-T therapy targeting haematologic malignancies and autoimmune diseases, and proprietary cell therapy manufacturing platform WILMINGTON, Del… Read More

A detailed analysis of the Global T-Cell Therapy Market 2023 is provided, including global, regional, and country-level market sizes, segmentation market growth, market share, comp… Read More

The world of advanced therapeutics medicinal products (ATMPs) particularly the cell and gene therapies (C&GT) space has been experiencing outstanding growth over the last few years, with… Read More

Immune evasion, a recognized hallmark of cancer, has been a central focus in oncology research for developing novel therapeutics. The field of immuno-oncology has emerged as a specialized br… Read More

… Read More

DelveInsight’s, “CAR-T Therapy Pipeline Insight 2023” report provides comprehensive insights about 200+ companies and 252+ pipeline drugs in the CAR-T Therapy pipeline lan… Read More

Immunotherapy In Cancer Treatment… Read More

Presented updated data from Phase 1 clinical trial of CT-0508 at CAR-TCR Summit, further supporting CAR-M safety, feasibility and mechanism of action Selected clinical candidate for CT-111… Read More

Designed to Protect Immunocompromised Patients Against Severe COVID-19 ATLANTA, GA – (NewMediaWire) – October 30, 2023 – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnolo… Read More

… Read More

Cancer immunotherapy holds enormous potential in combating malignant tumors. Messenger ribonucleic acid (mRNA) has emerged as a widely studied tool in recent years, functioning within the cy… Read More

The global CAR T Cell Therapy Market is estimated to be valued at US$ 2.26 Billion in 2022 and is expected to exhibit a CAGR of 20.9% over the forecast period 2022-2030, as highlighted in a… Read More

Nipah Virus (NiV) and its Effects on Humans Nipah Virus (NiV) is a potentially fatal zoonotic virus with the potential to cause disease outbreaks in both humans and animals. It was first dis… Read More

[Research Report] The fish vccine market size was valued at US$ 355.88 million in 2022 and is projected to reach US$ 617.38 million by 2030. It is estimated to grow at a CAGR of 7.1% during… Read More

META CEO Mark Zuckerberg is celebrating two scientists for their innovative work in cancer treatment. Immunologists Carl June and Michel Sadelain were announced winners of the prestigi… Read More

The T cell receptor (TCR) therapy market refers to the global industry involved in the development, manufacturing, and commercialization of therapies that utilize T cell receptors for the tr… Read More

Zurcher Kantonalbank Zurich Cantonalbank, a renowned bank based in Switzerland, has recently increased its stake in Legend Biotech Co. by a significant margin. This boost amounts to 42.1% du… Read More

mRNA Synthesis Raw Materials Market Growth & Trends The global mRNA synthesis raw materials market size is projected to reach USD 3.3 billion by 2030, according to a new report b… Read More

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, CAR-T pipeline constitutes key companies continuously working towards developing CAR-T treatment therap… Read More

All About Immunotherapy June is the month for ‘World Environment Day’, ‘Father s Day’, and ‘Intern… Read More

Cancer, one of the leading causes of death globally, has long been a challenge for healthcare professionals to treat effectively. Traditional methods, such as chemotherapy, radiation, and su… Read More